LyGenesis Company
Regenerative-medicine company founded in 2017 in Pittsburgh, Pennsylvania. LyGenesis is pioneering ectopic organogenesis, where functional tissues (like liver, pancreas, thymus) are grown in lymph nodes. The approach aims to provide a less invasive, scalable alternative to organ transplantation. Its lead program, a cell therapy for end-stage liver disease, is advancing in clinical trials. (lygenesis.com)
Investors
%20.jpg)
Headquarters:
1710 Murray Ave, Suite 200, Pittsburgh, PA 15217, United States
Founded Date:
2017
Estimated Revenue:
No public info